Skip to content

Nestléfaces difficulties due to price increase tactics

Nestle® Increases Prices, Struggling Subsequently, Highlight on Corporate Performance and Stock

Nestlé faces potential issues due to price hikes it has instigated
Nestlé faces potential issues due to price hikes it has instigated

Nestléfaces difficulties due to price increase tactics

================================================================

In the world of finance, Nestle S.A., a global powerhouse in the food and beverage industry, is currently grappling with a short-term downturn. As of mid-August 2025, the company's shares (ticker: NSRGY) are on a negative trajectory, with a recent decline of 1.15% to $92.27 on July 25, 2025, and a predicted support level around $88.70 [1].

However, from a fundamental perspective, Nestle remains a robust company with a broad and diverse product portfolio spread globally. The stock is currently trading near $99.38 (August 18, 2025) with a large market cap of about $257.5 billion, a Price/Earnings normalized at 19.21, and a solid dividend yield of around 3.68%. Nestle is recognized for its geographic reach and brand diversity, which help buffer operational and market shocks [2].

Recent reports suggest that the poor sales figures and profitability issues at Nestle are the reasons for the former CEO's ousting in August [4]. The company has been criticized for not easing up quickly enough on price increases as inflation has cooled, compared to its competitors [5]. Additionally, concerns about health need to be seen in the context of Nestle's increasing emphasis on health and nutrition [6].

The trouble with IT last year and an uncomfortable regulatory investigation in France over allegations related to the purification of bottled mineral water are contributing factors to Nestle's tumbling targets [7]. Nestle is "counting the cost" of pushing up prices of its most popular brands beyond the reach of "increasingly squeezed customers" [8]. Underlying sales for Nestle increased by an unexpectedly weak 2% in the first nine months of this year [9].

Nestle's shares are down 14% in a year and close to their cheapest valuation in 10 years, at 18.4 times forward earnings [10]. The company's profitability is under pressure, with margins weakening [11]. A potential solution to improve Nestle's profitability could be a "hefty spend on sales and marketing", possibly funded by selling some of its 20% stake in L'Oréal [12].

Despite these challenges, Nestle's regional variants, such as Nestle India Ltd, show slightly positive movement in local markets [3]. Nestle's sales guidance has been cut again, expecting a 2% increase for the full year, the lowest rate since the turn of the century [13]. However, the group still has competitive advantages such as distribution clout, buying power with suppliers, and diverse household-name brands that underpin pricing power [14].

The company faces the medium- and long-term challenge that its portfolio is full of foods that may go out of fashion due to growing concern over rising rates of obesity [15]. Nestle's poor numbers have been discussed by Sian Bradley in The Times and Aimee Donnellan for Breakingviews [16].

Investors should weigh near-term technical challenges against the company's solid fundamentals and long-term prospects. While the short-term outlook may be uncertain, Nestle's robust portfolio, significant global scale, reasonable valuation metrics, and dividend income support a medium to long-term positive outlook.

[1] Source [2] Source [3] Source [4] Source [5] Source [6] Source [7] Source [8] Source [9] Source [10] Source [11] Source [12] Source [13] Source [14] Source [15] Source [16] Source

  1. Subscribing to a personal-finance newsletter could provide insights on the current situation and potential solutions to improve Nestle's profitability in the food and business industry.
  2. Personal finance enthusiasts may find it interesting to analyze Nestle's financials, including its market cap, price-to-earnings ratio, and dividend yield, as part of their investment strategy, despite the short-term downturn.

Read also:

    Latest